AMCP Comments on CMS Medicare Program; International Pricing Index Model for Medicare Part B Drugs

The Academy of Managed Care Pharmacy (AMCP) appreciates the opportunity to provide comments in response to Centers for Medicare & Medicaid Services’ (CMS) Advanced Notice of Proposed Rulemaking (ANPRM) on the Medicare Program; International Pricing Index Model for Medicare Part B Drugs; [CMS5528-ANPRM]. AMCP is the nation’s leading professional association dedicated to increasing patient access to affordable medicines, improving health outcomes and ensuring the wise use of health care dollars. Through evidence- and value-based strategies and practices, the Academy’s 8,000 pharmacists, physicians, nurses and other practitioners manage medication therapies for the 270 million Americans served by health plans, pharmacy benefit management firms, emerging care models and government.

View More

Related